Biophysics Seminar
2006/2007 | 2007/2008 | 2008/2009 | 2009/2010 | 2010/2011 | 2011/2012 | 2012/2013 | 2013/2014 | 2014/2015 | 2015/2016 | 2016/2017 | 2017/2018 | 2018/2019 | 2019/2020 | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025
2024-11-15 (Friday)
dr Simon Drew (IFD UW)
Bio:Simon obtained a PhD specialising in paramagnetic resonance spectroscopy from the School of Physics, Monash University, Australia, in 2002. This was followed by postdoctoral research in magnetic resonance imaging (2002–2004) and bioinorganic chemistry (2004–2006) at the Centre for Magnetic Resonance, University of Queensland, Australia. From 2006–2009, he was a research fellow in the Department of Pathology, University of Melbourne, Australia, gaining wet-lab experience in the biosciences. In 2010–2011, he obtained valuable international experience at the Max Planck Institute for Bioinorganic Chemistry, Germany, before returning to the University of Melbourne to start an independent laboratory in the Florey Department of Neuroscience and Mental Health (2012–2016) and the Department of Medicine (2017–2018). He subsequently relocated to the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (2018–2021) and was a visiting scientist at the Pasteur Institute, Paris (2022–2023). He remains an honorary research fellow in the Department of Medicine (Royal Melbourne Hospital), University of Melbourne.
Biophysical characterisation of copper-binding proteins: the good, the bad, and the irrelevant
This presentation will provide an overview of my past research, with a special emphasis on applications of EPR spectroscopy to copper-binding peptides and proteins involved in health and disease. I will also outline my current interests and future research goals.
Bio:Simon obtained a PhD specialising in paramagnetic resonance spectroscopy from the School of Physics, Monash University, Australia, in 2002. This was followed by postdoctoral research in magnetic resonance imaging (2002–2004) and bioinorganic chemistry (2004–2006) at the Centre for Magnetic Resonance, University of Queensland, Australia. From 2006–2009, he was a research fellow in the Department of Pathology, University of Melbourne, Australia, gaining wet-lab experience in the biosciences. In 2010–2011, he obtained valuable international experience at the Max Planck Institute for Bioinorganic Chemistry, Germany, before returning to the University of Melbourne to start an independent laboratory in the Florey Department of Neuroscience and Mental Health (2012–2016) and the Department of Medicine (2017–2018). He subsequently relocated to the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (2018–2021) and was a visiting scientist at the Pasteur Institute, Paris (2022–2023). He remains an honorary research fellow in the Department of Medicine (Royal Melbourne Hospital), University of Melbourne.
2024-11-08 (Friday)
dr Piotr Brągoszewski (Narodowy Instytut Onkologii)
Safeguarding mitochondrial protein transport: proteolytic mechanisms in action
Most mitochondrial proteins begin as precursors in the cytosol and are imported into the organelle through specialized translocation channels. If a protein misfolds during this process, it may stall, blocking further import and disrupting mitochondrial function and protein homeostasis. We compared molecular mechanisms handling failed import events in yeast and human cells. Our experiments revealed that yeast cells primarily rely on the cytosolic ubiquitin-proteasome system, while human cells depend more on mitochondrial factors. Our findings suggest that understanding these mechanisms could provide insights into human diseases related to protein misfolding.
2024-10-25 (Friday)
dr Monika Wojciechowska (CeNT UW)
Antibiotic resistance is doing well - a challenge and proposed strategies to combat the global threat
Combating antibiotic-resistant pathogens has become one of the greatest challenges facing modern science. The overuse of antibiotics has led to a sharp increase in bacterial resistance, particularly after the COVID-19 outbreak. As a result, the development of new, effective antibacterial agents is crucial. Membrane-active peptides hold significant potential for creating new antimicrobials. However, their therapeutic use is limited by factors such as susceptibility to proteolytic degradation and potential toxicity to mammalian cells.By stabilizing the conformations of membrane-active peptides and adapting their specific properties, we have been able to mitigate these limitations. The peptides we have modified show activity against both Gram-negative and Gram-positive strains and are non-hemolytic. Our findings pave the way for designing new classes of amphipathic peptides and will contribute to the development of novel antibacterial agents
2024-10-11 (Friday)
prof Joanna Sułkowska (CeNT UW)
Bio: Dr hab. Joanna Sułkowska, prof. UW is a head of the "Interdisciplinary laboratory for modeling biological systems" at the Centre of New Technologies at the University of Warsaw. In 2007 she defended with distinction her doctoral dissertation in the field of biophysics, devoted to the characteristics of mechanical properties of proteins. In 2016 she obtained her habilitation at the Faculty of Chemistry of the University of Warsaw and professor position in 2018. For several years, as part of a postdoctoral internship, she worked at the University of California, San Diego. She spent several months as a visiting professor at MIT and the California Institute of Technology. She is an author of over 80 scientific publications, including Nature Structure & MB, JACS, PNAS, PRL, NAR, where she combines theoretical approach with experimental data. For her greatest scientific achievement so far, she considers a discovery and characterization of non-trivial topology in proteins such as knots, slipknots, lassos and theta curves, the determination of mechanisms of their formation and relationships with biological function. She has also worked successfully on antagonists for GPCR-type proteins (CB1 and CB2).Joanna Sulkowska has been awarded many times for her scientific achievements. She received e.g. Installation and Young Investigator award from the European Molecular Biology Organization (EMBO), grants from the National Science Centre, the Foundation for Polish Science, and the Ministry of Science and Higher Education in Poland (Idea Plus based on ERC Starting grant application). She is the winners of the 2018 National Science Centre Award in Poland in the field of Life Sciences (for people under 40 years), and award from MNiSW, 2020. She received the international prize Unesco-L'Oreal ''Rising talent''. She was chosen as a person of the year “MocArty – 2017” by Polish RMF Classic. She was also ranked among the group of 50 brave people and in the initiative Jutronauci by Gazeta Wyborcza (PL) in 2017. She gave as well many public lectures.
Knot or not? Application of Machine Learning models in structural biology
Recent advances in Machine Learning methods in structural biology opened up new perspectives for protein analysis. Utilizing these methods allows us to go beyond the limitations of empirical research, and take advantage of the vast amount of generated data. We use a complete set of potentially knotted protein models identified in all high-quality predictions from the AlphaFold Database to search for any common trends that describe them [1,2]. We show that the vast majority of knotted proteins have the simplest type of knot and that the presence of knots is preferred in neither Bacteria, Eukaryota, or Archaea domains. On the contrary, the percentage of knotted proteins in any given proteome is around 0.4%, regardless of the taxonomical group. Moreover, we show through structural biology methods (X-ray, Cryo-EM), that AF can predict new types of knot in proteins [3] and neural network type models (NN) can be used to detect topology based on geometry [4] and LSTM is a good approach to. design protein with non-trivial topology [5]. In addition, I briefly discuss the use of quantum methods in combination with classical molecular dynamics and AF approach to determine the methylation reactions pathway based on knotted tRNA methyltransferases [6,7,8].1. Everything AlphaFold tells us about protein knots, A Perlinska, M Sikora, JI Sulkowska Journal of Molecular Biology (2024)2. AlphaKnot: server to analyze entanglement in structures predicted by AlphaFold methods, W Niemyska, P Rubach, BA Gren, ML Nguyen, W Garstka, F Bruno da Silva, EJ Rawdon, JI Sulkowska, Nucleic Acids Research (2022) 3. First crystal structure of double knotted protein TrmD-Tm1570 – inside from degradation perspective, B da Silva, I Lewandowska, A Kluza, S Niewieczerzal, R Augustyniak, JI Sulkowska, 2024 JACS (under review)4. Knots and θ-Curves Identification in Polymeric Chains and Native Proteins Using Neural Networks, Bruno da Silva, F., Gabrovšek, B., Korpacz, M., Luczkiewicz, K., Niewieczerzal, S., Sikora, M., & Sulkowska, J. I. Macromolecules (2024), 57(9)5. Knot or not? Identifying unknotted proteins in knotted families with sequence-based Machine Learning model, M Sikora, E Klimentova, D Uchal, D Sramkova, AP Perlinska, ML Nguyen, M Korpacz, R Malinowska, S Nowakowski, P Rubach, P Simecek, JI SulkowskaProtein Science (2024), 33 (7)6. Nucleolar Essential Protein 1 (Nep1): Elucidation of enzymatic catalysis mechanism by molecular dynamics simulation and quantum mechanics study, M Jedrzejewski, B Belza, I Lewandowska, M Sadlej, AP Perlinska, R Augustyniak, T Christian, Y Hou, M Kalek, JI Sulkowska, Computational and Structural Biotechnology Journal (2023)7. Mg2+-Dependent Methyl Transfer by a Knotted Protein: A Molecular Dynamics Simulation and Quantum Mechanics Study, AP Perlinska, M Kalek, Y-M Hou, JI Sulkowska, ACS Catalysis (2020) 10(15):8058-80688. Methyl Transfer by Substrate Signaling from a Knotted Protein FoldT Christian*, R Sakaguchi*, AP Perlinska*, G Lahoud, T Ito, EA Taylor, S Yokoyama, JI Sulkowska, Y-M Hou, Nature Structural & Molecular Biology (2016) 23: 941-948
Bio: Dr hab. Joanna Sułkowska, prof. UW is a head of the "Interdisciplinary laboratory for modeling biological systems" at the Centre of New Technologies at the University of Warsaw. In 2007 she defended with distinction her doctoral dissertation in the field of biophysics, devoted to the characteristics of mechanical properties of proteins. In 2016 she obtained her habilitation at the Faculty of Chemistry of the University of Warsaw and professor position in 2018. For several years, as part of a postdoctoral internship, she worked at the University of California, San Diego. She spent several months as a visiting professor at MIT and the California Institute of Technology. She is an author of over 80 scientific publications, including Nature Structure & MB, JACS, PNAS, PRL, NAR, where she combines theoretical approach with experimental data. For her greatest scientific achievement so far, she considers a discovery and characterization of non-trivial topology in proteins such as knots, slipknots, lassos and theta curves, the determination of mechanisms of their formation and relationships with biological function. She has also worked successfully on antagonists for GPCR-type proteins (CB1 and CB2).Joanna Sulkowska has been awarded many times for her scientific achievements. She received e.g. Installation and Young Investigator award from the European Molecular Biology Organization (EMBO), grants from the National Science Centre, the Foundation for Polish Science, and the Ministry of Science and Higher Education in Poland (Idea Plus based on ERC Starting grant application). She is the winners of the 2018 National Science Centre Award in Poland in the field of Life Sciences (for people under 40 years), and award from MNiSW, 2020. She received the international prize Unesco-L'Oreal ''Rising talent''. She was chosen as a person of the year “MocArty – 2017” by Polish RMF Classic. She was also ranked among the group of 50 brave people and in the initiative Jutronauci by Gazeta Wyborcza (PL) in 2017. She gave as well many public lectures.
2024-10-04 (Friday)
Denis Koltsov (HORIBA)
Particle Tracking Analysis in biophysics and other areas
Since the first commercial implementations of particle tracing analysis in 2010s the uptake of this method has grown and took over some of the particle- and dispersion-based areas of science and production. This presentation focuses on the application of particle sizing, counting and tracking for biological and pharma applications with relevant method descriptions, capabilities and limitations. We also outline common experimental setups and unique features of three-laser system for number concentration measurements, sizing very polydisperse samples and using florescence methods for tagging. This presentation is aimed to bring the best PTA technology to mainstream universities and companies